查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1989990

腹部缝合系统市场：按产品类型、材料、应用、最终用户和分销管道分類的全球市场预测，2026-2032年

Abdominal Closure System Market by Product Type, Material, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，腹部缝合系统市场价值将达到 1.9036 亿美元，到 2026 年将成长至 2.0524 亿美元，到 2032 年将达到 3.4654 亿美元，复合年增长率为 8.93%。

主要市场统计数据
基准年 2025 1.9036亿美元
预计年份：2026年 2.0524亿美元
预测年份 2032 3.4654亿美元
复合年增长率 (%) 8.93%

腹部闭合系统的全面概述：临床意义、技术进步、相关人员的角色和手术安全重点。

腹部缝合系统领域处于外科技术、材料科学和医疗设备工程的关键交叉点，即使是微小的进步也会直接影响患者的治疗结果。本文概述了临床上对可靠且可重复的腹部缝合解决方案的需求，并重点介绍了推动产品发展的关键技术方向。透过将医疗设备创新与不断变化的手术偏好以及对手术全期安全性的日益关注相结合，本文为临床、监管和商业相关人员建立了一个策略决策框架。

生物材料的创新、医疗设备的改进、手术偏好的改变以及综合手术模式的出现，推动了腹部缝合技术的变革性发展。

腹部缝合系统领域正经历变革，这得益于技术进步、临床实践的改变以及采购模式的演变。生物材料的创新提高了黏合剂的生物相容性并优化了其降解特性，而器械的小型化和符合人体工学的设计则提升​​了操作便利性和手术速度。同时，临床医师的需求也日益趋向于能够缩短手术时间和降低併发症风险的解决方案，促使研发人员更加重视简化工作流程和提升系统层面的综合价值。

分析 2025 年美国关税措施对供应链、零件采购、采购方式和医院采购的累积影响。

2025年美国关税措施的累积影响，为整个腹部缝合生态系统的供应链设计、零件采购和采购实践带来了新的转折点。影响进口原料、聚合物组件和成品的关税措施凸显了原料集中度风险，促使製造商重新评估其采购地点，并加快替代供应商的认证。实际上，这意味着对医疗设备组件关税分类的审查力度加大，海关合规活动增多，以及对整个国际供应商网路中的到岸成本进行更积极的管理。

细分市场洞察，探索产品类型、生物材料、临床应用、最终用户和分销管道如何相互交织并影响产品选择。

细分市场分析深入观点了临床需求、材料科学和采购管道如何相互交织，共同影响产品的开发和应用。从产品类型来看，腹部缝合解决整体情况涵盖了黏合剂、夹子、网片系统、缝合钉和缝线，每个类别都有其独特的临床和商业性考虑。黏合剂可进一步分为纤维蛋白胶和组织黏合剂，分别对应不同的生物创伤治疗特性和应用技术。夹子有金属和聚合物两种材质，选择时通常需要考虑渗透性、生物相容性和成本之间的平衡。网片系统分为生物来源和合成两种。生物来源网片取自牛或猪的组织，而合成网片通常由聚酯或聚丙烯製成，每种材料在与宿主组织的整合性和抗拉强度方面都表现出不同的特性。缝合钉有手动和电动两种类型，反映了人们对手术效率和操作性的偏好。缝线则分为可吸收和不可吸收两种选择。可吸收缝线使用Polyglactin910和聚乙醇酸等材料，而不可吸收缝线则使用尼龙和聚丙烯等材料。这些材料的选择取决于所需的缝合效果持续时间和组织反应。

针对美洲、欧洲、中东和非洲以及亚太地区的区域洞察，重点在于供应链韧性、临床引入模式和监管差异。

区域趋势对腹部缝合系统的临床导入路径、监管互动和供应链设计有显着影响。在美洲，采购流程的完善和采购集团的整合为规模化生产创造了机会，同时也带来了压力，需要证明其具有可靠的临床证据和整体成本优势。该地区公立和私立医疗机构并存的现状凸显了经营模式的必要性，使其能够适应不同的合约週期和基于价值的论点。欧洲、中东和非洲（EMEA）地区的法规环境复杂，医疗资金筹措模式多样，因此需要製定适应性强的监管策略和灵活的商业性模式，以适应各国的报销体系和不同的临床实践规范。在许多EMEA市场，当地的註册要求和公共采购流程会显着影响产品导入时间，因此与国家意见领袖进行有针对性的沟通至关重要。

专注于竞争定位、产品系列、策略联盟、研发重点和打入市场策略的企业洞察，从而推动企业保持领先地位。

腹部缝合领域的企业透过整合产品组合深度、材料专业知识和策略性商业性关係来脱颖而出。业界领导企业优先投资研发，以改善生物材料并开发能够减轻临床医生负担、同时维持或改善临床疗效的器械配置。与契约製造、学术机构和临床网路建立伙伴关係和合作对于加速研发週期和获得可靠的临床检验至关重要。拥有涵盖黏合剂、网片、缝合钉和缝合系统等多元化产品系列的企业更有能力提供整合解决方案，满足整体外科手术的需求，并在医院采购框架内扩大市场份额。

为领导者提供可操作的建议，以加速创新、加强供应链、简化采购流程，并将临床重点与商业性执行结合。

腹部缝合领域的领导者应采取一系列切实可行的操作步骤，将洞见转化为可衡量的优势。首先，他们应优先投资于生物材料研究，并专注于生物相容性和机械性能之间的平衡。与临床合作伙伴共同设计试验将提高研究的相关性并加速其应用。其次，他们应实现供应商关係多元化，并探索近岸外包和双重采购策略，以减少对特定地区的依赖，并减轻关税和物流中断的影响。第三，他们应透过整合训练、临床结果数据和符合医院价值导向采购要求的捆绑式服务，来增强商业性提案。

调查方法概述，涵盖研究设计、一级和二级调查、专家访谈、检验以及证据整合的分析方法。

本研究设计结合了质性研究和全面的第二手资料，建构了多层次的证据基础。主要活动包括：对循环系统、普通外科、妇科和整形外科的临床医生进行结构化访谈；与门诊手术中心和医院的采购和供应链经理进行深入讨论；以及咨询监管机构和生产专家，以了解材料采购和合规方面的考虑。二手资料研究纳入了同行评审文献、监管指导文件以及公开的生物材料和手术结果技术规范，以便更好地理解从定性研究中获得的发现。

结论：整合关键的临床、技术、监管和商业性发现，以指导腹部缝合领域的策略决策和未来优先事项。

这个结论将临床需求、材料科学的进步、供应链现状和商业策略整合为一套连贯的洞见，为未来的工作提供指导。在所有产品类型中，材料选择和器械人体工学仍然是改善手术效果和加速临床接受度的关键驱动因素。关税和贸易环境为策略规划增添了新的维度，优先考虑加强供应链韧性和供应商多元化。美洲、欧洲、中东和非洲以及亚太地区的区域差异要求制定细緻的监管规划和差异化的商业化策略，以适应当地的市场接受度因素。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 腹部缝合系统市场：依产品类型划分

  • 黏合式封口
    • 纤维蛋白胶
    • 组织黏合剂
  • 夹子
    • 金属夹
    • 聚合物夹
  • 网格系统
    • 生物网膜
      • 源自牛
      • 源自猪
    • 复合网格
      • 聚酯纤维
      • 聚丙烯
  • 主食
    • 手动的
    • 电的
  • 缝合线
    • 吸收性
      • Polyglactin910
      • 聚乙醇酸
    • 不吸收
      • 尼龙
      • 聚丙烯

第九章 腹部缝合系统市场：依材料划分

  • 生物起源
    • 胶原蛋白
    • 猪源性细胞外基质
  • 合成
    • 聚酯纤维
    • 聚丙烯

第十章 腹部缝合系统市场：依应用划分

  • 心血管外科
  • 一般外科
  • 妇科手术
  • 整形外科

第十一章 腹部缝合系统市场：依最终用户划分

  • 门诊手术中心
    • 独立的
    • 医院附属机构
  • 医院
    • 私人的
    • 民众
  • 专科诊所

第十二章 腹部缝合系统市场：依分销管道划分

  • 离线
  • 在线的

第十三章 腹部缝合系统市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 腹部缝合系统市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 腹部缝合系统市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国腹部缝合系统市场

第十七章：中国腹部缝合系统市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • Abbott Laboratories
  • Absolutions Medical, Inc.
  • Aesculap AG
  • Applied Medical Technology, Inc.
  • B. Braun SE
  • Baxter International Inc.
  • Boston Scientific Corporation
  • Canica Design Inc.
  • CONMED Corporation
  • Corza Health, Inc.
  • Essity AB
  • Ethicon, Inc.
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Karl Storz SE & Co. KG
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Smith & Nephew plc
  • Teleflex Incorporated
  • WL Gore & Associates, Inc.
Product Code: MRR-CD5A9334D821

The Abdominal Closure System Market was valued at USD 190.36 million in 2025 and is projected to grow to USD 205.24 million in 2026, with a CAGR of 8.93%, reaching USD 346.54 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 190.36 million
Estimated Year [2026] USD 205.24 million
Forecast Year [2032] USD 346.54 million
CAGR (%) 8.93%

Comprehensive introduction to abdominal closure systems outlining clinical importance, technology evolution, stakeholder roles, and priorities for surgical safety

The abdominal closure system landscape occupies a critical intersection of surgical technique, material science, and device engineering, where small advances translate directly into improved patient outcomes. This introduction frames the clinical imperative for reliable, reproducible abdominal closure solutions while outlining the major technology vectors that are driving product evolution. By situating device innovation alongside changing procedural preferences and heightened emphasis on perioperative safety, the narrative establishes the context for strategic decision-making across clinical, regulatory, and commercial stakeholders.

To maintain coherence with evolving practice patterns, the introduction emphasizes how incremental improvements in adhesives, fastening systems, mesh design, and suture technology can reduce complication rates, shorten operative time, and contribute to more predictable postoperative recovery. It also highlights the role of multidisciplinary collaboration-between surgeons, materials scientists, and supply chain professionals-in translating laboratory advances into usable products in the operating room. Finally, the section clarifies the stakeholder priorities that typically govern adoption cycles, including demonstrable safety, ease of use, compatibility with diverse surgical workflows, and clarity in reimbursement or purchasing rationale, setting the stage for deeper analytical sections that follow.

Transformative shifts in abdominal closure driven by biomaterials innovation, device refinement, procedural preference evolution, and integrated surgical models

The landscape for abdominal closure systems is shifting under a confluence of technological progress, clinical practice changes, and evolving procurement models. Biomaterials innovation is unlocking adhesives and meshes with enhanced biocompatibility and tailored degradation profiles, while device miniaturization and ergonomics are improving handling and procedural speed. Concurrently, clinician-led preferences are moving toward solutions that reduce operating room time and lower complication risk, prompting developers to place greater emphasis on simplified workflows and integrated system-level value.

In addition, cross-disciplinary collaborations are fostering hybrid solutions that blend biologic and synthetic approaches to balance host integration and mechanical strength. Regulatory pathways and post-market surveillance requirements are also adapting to novel device-material combinations, exerting greater pressure on manufacturers to demonstrate long-term safety and performance. From a commercial perspective, distribution and contracting models are evolving as providers seek more flexible sourcing options and as digital procurement channels expand access beyond traditional direct-sales relationships. Taken together, these shifts are not only altering product roadmaps but are also reshaping how clinical evidence is generated, validated, and deployed to support adoption.

Analysis of the cumulative impact of United States tariff actions in 2025 on supply chains, component sourcing, procurement approaches, and hospital procurement

The cumulative impact of United States tariff actions in 2025 has introduced new inflection points for supply chain design, component sourcing, and procurement behaviour across the abdominal closure ecosystem. Tariff measures affecting imported raw materials, polymer components, and finished devices have increased the visibility of input-concentration risk, prompting manufacturers to re-evaluate sourcing footprints and to accelerate qualification of alternate suppliers. In practice, this has meant closer scrutiny of tariff classifications for device components, increased customs compliance activity, and more active management of landed costs across international supplier networks.

Hospitals and ambulatory centers have felt the downstream effects through procurement cycles, with purchasing teams increasingly focused on total cost of ownership and on contract terms that allow pass-through of increased input costs. Providers are also more likely to request greater transparency on component origin and to favor suppliers that can demonstrate resilient logistics or local assembly capabilities. Meanwhile, innovation teams at device manufacturers are reassessing design choices where material substitution could mitigate tariff exposure without compromising clinical performance.

To navigate the tariff environment, stakeholders are implementing a range of mitigation strategies. Manufacturers are evaluating nearshoring options and diversifying supplier bases to reduce single-source dependencies. Contractual terms are being revised to share risk with buyers, and inventory management practices are being adjusted to balance working capital with supply continuity. On the regulatory side, product teams are weighing the implications of component changes on regulatory filings and post-market obligations, ensuring that any material substitutions or manufacturing transfers retain equivalence in safety and effectiveness.

Ultimately, the tariff context has reinforced the strategic importance of supply chain agility, regulatory foresight, and commercial transparency. The combined effect has been an acceleration in practical supply network redesign, a renewed focus on supplier qualification, and an increased premium on products that can demonstrate consistent availability and predictable total acquiring costs under shifting trade conditions.

Segmentation insights exploring how product categories, biomaterials, clinical applications, end users, and distribution channels converge to shape selection

Segmentation analysis offers a lens to understand how clinical needs, material science, and purchasing channels intersect to shape product development and adoption. When viewed by product type, the universe of abdominal closure solutions spans adhesive closures, clips, mesh systems, staples, and sutures, with each category bringing distinct clinical and commercial considerations. Adhesive closures divide into fibrin sealants and tissue adhesives, which cater to different wound-healing biology and application techniques. Clips are available in metal and polymer variants, where the choice often balances radiopacity, biocompatibility, and cost. Mesh systems bifurcate into biological and synthetic options; biological meshes can be sourced from bovine or porcine tissues, while synthetic meshes are typically polyester or polypropylene, each material offering a different profile for host integration and tensile properties. Staples arrive as manual and powered formats, reflecting preferences for procedural efficiency and ergonomics. Sutures present choices between absorbable and nonabsorbable materials; absorbable threads are often polyglactin 910 or polyglycolic acid, while nonabsorbable options include nylon and polypropylene, decisions that hinge on desired longevity and tissue response.

Material-based segmentation further clarifies clinical trade-offs. Biological materials such as collagen and porcine extracellular matrix are valued for their remodelling potential and compatibility with contaminated fields, whereas synthetic options like polyester and polypropylene provide predictable mechanical strength and long-term durability. Application-driven segmentation highlights divergence in requirement sets across cardiovascular, general, gynecological, and orthopedic surgery, with each area imposing unique mechanical demands and infection-risk profiles. The end-user perspective, spanning ambulatory surgical centers, hospitals, and specialty clinics, influences product selection, purchasing cadence, and service expectations; ambulatory surgical centers include freestanding and hospital-affiliated models, hospitals split between private and public ownership, and specialty clinics often seek niche solutions with focused support packages. Distribution channels-direct sales, distributors, and online platforms-shape commercial reach and pricing dynamics and determine how training, evidence dissemination, and post-sale support are delivered. By synthesizing these segmentation dimensions, stakeholders can identify where a given product aligns with clinical requirements, procurement practices, and distribution realities, thereby informing development priorities and go-to-market positioning.

Regional insights for the Americas, EMEA, and Asia-Pacific emphasizing supply chain resilience, clinical adoption patterns, and regulatory differences

Regional dynamics exert substantial influence on clinical adoption pathways, regulatory interactions, and supply chain design for abdominal closure systems. In the Americas, procurement sophistication and consolidated purchasing groups create both opportunities for scale and pressures for robust clinical evidence and favorable total cost narratives. The region's mix of private and public providers places a premium on commercial models that can accommodate varied contracting cycles and value-based discussions. Europe, Middle East & Africa presents a complex regulatory mosaic and heterogeneous healthcare financing models, demanding adaptable regulatory strategies and flexible commercial approaches that account for national reimbursement schemes and differing clinical practice norms. In many EMEA markets, local registration requirements and public procurement processes shape time-to-adoption and necessitate targeted engagement with national opinion leaders.

Asia-Pacific offers a combination of rapid clinical adoption in certain hubs and cost-sensitive procurement in others, driving manufacturers to pursue tiered product offerings and manufacturing footprints that address regional cost structures. Across Asia-Pacific, regulatory modernization in several jurisdictions has opened pathways for innovative materials, but variability in standards still requires tailored regulatory dossiers and localized clinical data. Supply chain considerations vary across regions: proximity to raw material sources, regional manufacturing capabilities, and logistics infrastructure determine lead times and inventory strategies. For international suppliers, regional regulatory heterogeneity and differing clinical preferences mean that a one-size-fits-all approach is rarely effective; instead, differentiated portfolios, flexible pricing constructs, and region-specific clinical evidence packages are required to achieve sustainable penetration. Overall, regional insights underscore the necessity of aligning regulatory planning, manufacturing strategy, and commercial execution with the unique demands of the Americas, Europe, Middle East & Africa, and Asia-Pacific.

Company insights highlighting competitive positioning, product portfolios, strategic alliances, R&D priorities, and go-to-market strategies that drive leadership

Companies operating in the abdominal closure domain are distinguishing themselves through a blend of portfolio depth, materials expertise, and strategic commercial relationships. Industry leaders prioritize investments in R&D to refine biomaterials and to develop device configurations that reduce clinician burden while preserving or enhancing clinical outcomes. Partnerships and alliances-whether with contract manufacturers, academic centers, or clinical networks-have become central to accelerating development cycles and gaining credible clinical validation. Firms with diversified product portfolios that span adhesives, meshes, staples, and suture systems are better positioned to provide bundled solutions, address cross-surgical needs, and capture a larger share of hospital purchasing frameworks.

Competitive positioning is also shaped by go-to-market models. Companies that combine direct-sales engagement with distributor relationships and digital channels can reach a broader set of end users while tailoring commercial terms to account for the purchasing preferences of freestanding ambulatory surgical centers, hospital-affiliated ASCs, private and public hospitals, and specialty clinics. Value-added services-such as surgeon training programs, clinical data repositories, and bundled contracting options-strengthen customer relationships and create higher switching costs. Additionally, firms that cultivate robust quality systems and transparent supply-chain traceability are gaining preference among procurement teams that demand auditability and continuity of supply. Mergers and acquisitions continue to be tools for acquiring novel biomaterials expertise, expanding geographic reach, and accelerating entry into adjacent procedural areas. Taken together, these strategic choices define a competitive landscape where technical excellence, commercial adaptability, and evidence-based engagement determine market leadership.

Practical recommendations enabling leaders to accelerate innovation, strengthen supply chains, streamline procurement, and synchronize clinical priorities with commercial execution

Leaders in the abdominal closure sector should adopt a set of pragmatic, operationally focused actions to translate insight into measurable advantage. First, prioritize targeted investment in biomaterials research that balances host integration with mechanical performance; working with clinical partners to co-design trials will increase relevance and accelerate adoption. Second, diversify supplier relationships and consider nearshoring or dual-sourcing strategies to reduce dependency on single geographies and to mitigate tariff or logistics shocks. Third, strengthen commercial propositions by integrating training, clinical outcomes data, and bundled offerings that align with hospital value-based purchasing requirements.

In parallel, manufacturers and providers should modernize procurement frameworks to emphasize total cost of ownership, supply transparency, and predictable lead times. Embedding contractual mechanisms that allow for cost-sharing and clear escalation clauses will reduce friction when input prices shift. Regulatory readiness must be elevated: any material substitutions or manufacturing transfers should be preceded by rigorous equivalence testing and regulatory consultation to avert post-market complications. Finally, invest in clinician engagement by providing hands-on training, evidence summaries, and real-world performance data, and consider digital tools to capture outcomes and inform iterative product improvements. These actions, taken together, will enhance resilience, facilitate smoother adoption, and support sustainable commercial performance.

Methodology summary covering research design, primary and secondary data collection, expert interviews, validation, and analytic methods for evidence synthesis

The research design combined primary qualitative inquiry with comprehensive secondary synthesis to produce a multilayered evidence base. Primary activities included structured interviews with clinicians across cardiovascular, general, gynecological, and orthopedic specialties, in-depth discussions with procurement and supply chain leaders from ambulatory surgical centers and hospitals, and consults with regulatory and manufacturing experts to understand material sourcing and compliance considerations. Secondary research incorporated peer-reviewed literature on biomaterials and surgical outcomes, regulatory guidance documents, and publicly available technical specifications to contextualize primary insights.

Analytic techniques emphasized triangulation and validation. Interview findings were coded thematically and cross-referenced with secondary sources to identify convergent signals and to expose areas of divergence requiring further inquiry. Supply chain mapping and component provenance analysis were employed to uncover concentration risks and to evaluate potential mitigation pathways. Validation steps included iterative review sessions with external subject matter experts and cross-checks against regulatory precedents to ensure the accuracy of technical characterizations. The approach balanced qualitative depth with systematic verification to produce robust, actionable insights suitable for commercial and clinical decision-making.

Conclusion synthesizing key clinical, technological, regulatory, and commercial insights to guide strategic decisions and future priorities in abdominal closure

The concluding synthesis brings together clinical imperatives, material science developments, supply chain realities, and commercial strategy into a coherent set of insights to inform next steps. Across product categories, materials choices and device ergonomics remain primary levers for improving surgical outcomes and accelerating clinical acceptance. The tariff and trade environment has added a new dimension to strategic planning, elevating supply chain resilience and supplier diversification as priority initiatives. Regional heterogeneity-spanning the Americas, Europe, Middle East & Africa, and Asia-Pacific-requires nuanced regulatory planning and differentiated commercialization strategies to match local adoption drivers.

Companies that combine disciplined R&D investment, transparent supply chain practices, and adaptive commercial models will be best positioned to meet provider needs and to sustain long-term engagement. Providers and procurement teams, for their part, should seek partnerships that offer predictable supply, clear clinical evidence, and flexible contracting options. In sum, the evidence supports a balanced approach that simultaneously advances technical innovation, strengthens operational resilience, and aligns commercial execution with the practical demands of surgical teams and health system purchasers. This integrated perspective provides a pragmatic foundation for prioritizing initiatives that will yield durable clinical and commercial benefits.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Abdominal Closure System Market, by Product Type

  • 8.1. Adhesive Closures
    • 8.1.1. Fibrin Sealants
    • 8.1.2. Tissue Adhesive
  • 8.2. Clips
    • 8.2.1. Metal Clips
    • 8.2.2. Polymer Clips
  • 8.3. Mesh Systems
    • 8.3.1. Biological Mesh
      • 8.3.1.1. Bovine
      • 8.3.1.2. Porcine
    • 8.3.2. Synthetic Mesh
      • 8.3.2.1. Polyester
      • 8.3.2.2. Polypropylene
  • 8.4. Staples
    • 8.4.1. Manual
    • 8.4.2. Powered
  • 8.5. Sutures
    • 8.5.1. Absorbable
      • 8.5.1.1. Polyglactin 910
      • 8.5.1.2. Polyglycolic Acid
    • 8.5.2. Nonabsorbable
      • 8.5.2.1. Nylon
      • 8.5.2.2. Polypropylene

9. Abdominal Closure System Market, by Material

  • 9.1. Biological
    • 9.1.1. Collagen
    • 9.1.2. Porcine Extracellular Matrix
  • 9.2. Synthetic
    • 9.2.1. Polyester
    • 9.2.2. Polypropylene

10. Abdominal Closure System Market, by Application

  • 10.1. Cardiovascular Surgery
  • 10.2. General Surgery
  • 10.3. Gynecological Surgery
  • 10.4. Orthopedic Surgery

11. Abdominal Closure System Market, by End User

  • 11.1. Ambulatory Surgical Centers
    • 11.1.1. Freestanding
    • 11.1.2. Hospital-Affiliated
  • 11.2. Hospitals
    • 11.2.1. Private
    • 11.2.2. Public
  • 11.3. Specialty Clinics

12. Abdominal Closure System Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Abdominal Closure System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Abdominal Closure System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Abdominal Closure System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Abdominal Closure System Market

17. China Abdominal Closure System Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 3M Company
  • 18.6. Abbott Laboratories
  • 18.7. Absolutions Medical, Inc.
  • 18.8. Aesculap AG
  • 18.9. Applied Medical Technology, Inc.
  • 18.10. B. Braun SE
  • 18.11. Baxter International Inc.
  • 18.12. Boston Scientific Corporation
  • 18.13. Canica Design Inc.
  • 18.14. CONMED Corporation
  • 18.15. Corza Health, Inc.
  • 18.16. Essity AB
  • 18.17. Ethicon, Inc.
  • 18.18. Integra LifeSciences Corporation
  • 18.19. Johnson & Johnson Services, Inc.
  • 18.20. Karl Storz SE & Co. KG
  • 18.21. Medtronic plc
  • 18.22. Meril Life Sciences Pvt. Ltd.
  • 18.23. Smith & Nephew plc
  • 18.24. Teleflex Incorporated
  • 18.25. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ABDOMINAL CLOSURE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FIBRIN SEALANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FIBRIN SEALANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY TISSUE ADHESIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY TISSUE ADHESIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY TISSUE ADHESIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY METAL CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY METAL CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY METAL CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYMER CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYMER CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYMER CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BOVINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BOVINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BOVINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POWERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POWERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POWERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLACTIN 910, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLACTIN 910, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLACTIN 910, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NYLON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NYLON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NYLON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COLLAGEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COLLAGEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE EXTRACELLULAR MATRIX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE EXTRACELLULAR MATRIX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PORCINE EXTRACELLULAR MATRIX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FREESTANDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FREESTANDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITAL-AFFILIATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITAL-AFFILIATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITAL-AFFILIATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 246. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2032 (USD MILLION)
  • TABLE 250. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 252. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 254. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 256. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 260. MIDDLE EAST ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2032 (USD MILLION)
  • TABLE 264. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 268. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2032 (USD MILLION)
  • TABLE 269. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 270. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 271. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 272. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 273. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 274. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 275. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 278. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 279. AFRICA ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2032 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 299. GLOBAL ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 300. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 301. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ADHESIVE CLOSURES, 2018-2032 (USD MILLION)
  • TABLE 303. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 304. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MESH SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 305. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL MESH, 2018-2032 (USD MILLION)
  • TABLE 306. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC MESH, 2018-2032 (USD MILLION)
  • TABLE 307. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY STAPLES, 2018-2032 (USD MILLION)
  • TABLE 308. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 309. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY ABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 310. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY NONABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 311. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 312. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY BIOLOGICAL, 2018-2032 (USD MILLION)
  • TABLE 313. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 314. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 315. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 316. ASEAN ABDOMINAL CLOSURE SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-203